News Snapshot:
Chinese researchers and drug manufacturers are among the frontrunners in COVID-19 drug research and development (R&D), and they are closely working with international partners, experts said, after Sinopharm revealed the world's first COVID-specific drug based on vaccinated people's plasma at the 2021 China International Fair for Trade in Services. (Photo: CNBG) China also has an advantage in applying traditional Chinese medicine (TCM) to treat COVID-19, experts noted. Overall, it is more difficult to develop effective drugs than it is for vaccines, as doing so in a way that's safe for patients requires deeper understanding of the virus, Shanghai-based expert Tao...
